Be in the know. 12 key reads for Friday…

  1. Wells Fargo names BNY Mellon’s Charles Scharf as CEO (Reuters)
  2. Baird Says US Banks Still Have Big Value: 4 to Buy Now (24/7 Wall Street)
  3. What Exxon Mobil and Chevron Could Buy Next, According to Morgan Stanley (Barron’s)
  4. China trade talks are set to resume on October 10 (CNBC)
  5. Wall Street Democratic donors warn the party: We’ll sit out, or back Trump, if you nominate Elizabeth Warren (CNBC)
  6. Hedge Funds Struggle to Replicate Warren Buffett’s Reinsurance Success (Bloomberg)
  7. Las Vegas Sands (LVS) will replace Nektar Therapeutics (NKTR) in S&P 500 (StreetInsider)
  8. China’s top diplomat says Beijing willing to buy more U.S. products (Reuters)
  9. New Kinder Morgan pipeline frees natgas long-trapped in Permian (Yahoo! Finance)
  10. These three stocks are overlooked and undervalued, says Greenwich Wealth (MarketWatch)
  11. LNG Buyers Fret Over Feast-or-Famine Forecasts (Wall Street Journal)
  12. Oil drops after Iran’s president said US offered to remove all sanctions in exchange for talks (CNBC)

 

Be in the know. 15 key reads for Thursday…

  1. The Fed will be growing its balance sheet again, but don’t call it ‘QE4’ (CNBC)
  2. James Bullard says the Fed still has a ‘little more to go’ with rate cuts (CNBC)
  3. Hedge Fund and Insider Trading News: Tiger Global Management, Elliott Management, Aldeyra Therapeutics Inc (ALDX), Restoration Hardware Holdings, Inc (RH), and More (Insider Monkey)
  4. Drug-Price Legislation Unlikely Before Election, Analyst Says (Barron’s)
  5. China says in close communication with U.S. over October trade talks (Reuters)
  6. Netflix Stock Has Taken a Beating. Here’s How to Play a Bounceback. (Barron’s)
  7. Trump Announces a Trade Pact With Japan (New York Times)
  8. Latinos may be the key to future US economic growth, study argues (CNBC)
  9. AbbVie Is Up After Another Analyst Reconsidered Its Allergan Acquisition and Upgraded the Stock (Barron’s)
  10. Wells Fargo acting chief Parker likely to get job by default (Yahoo! Finance)
  11. Despite Setbacks, Biogen is a Buy for Value Investors (Yahoo! Finance)
  12. 4 Blue-Chip Large-Cap Stocks That All Yield a Massive 7% or More (24/7 Wall Street)
  13. Millennials Continue to Leave Big Cities (Wall Street Journal)
  14. Trump Says Impeachment Could Derail U.S.-Mexico-Canada Trade Deal (Wall Street Journal)
  15. An Unimpeachable Reason to Buy Stocks (Wall Street Journal)